ARCHIVES

Phase III Five-Year Data Show Erbitux Increases Survival Of Head And Neck Cancer

This article is from The Cancer Letter archive.

Vol. 31 No. 9 | September 26, 2008

Download PDF Visit The Full Archive

Related Articles

Two Workshops To Look For New Research Areas

October 29, 1976

December Business & Regulatory Report included in this issue.

December 12, 2003

NCI Advisors To Gain Increased Responsibility For Concept, Technical Merit Review Of Contracts

December 19, 1980

FDA, Clinical Investigators Head Or Showdown Over Demand To See Individual Patient Records

April 18, 1980

NEJM Says Henschke Conflicts Irrelevant; Propriety Of Granting CME Questioned.

March 14, 2008

Protocols Approved During The Month of September 2001

October 26, 2001